About Apollo Endo
Apollo Endo is a company based in Austin (United States) founded in 2005 was acquired by Boston Scientific in November 2022.. Apollo Endo has raised $80.36 million across 13 funding rounds from investors including Boston Scientific, UTMB Health and PTV Healthcare Capital. The company has 132 employees as of December 31, 2022. Apollo Endo offers products and services including Endoscopic Sleeve Gastroplasty (ESG), Transoral Outlet Reduction (TORe), and Orbera. Apollo Endo operates in a competitive market with competitors including Allurion, USGI Medical, ReShape, Cyted and Vibrynt, among others.
- Headquarter Austin, United States
- Employees 132 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Apollo Endosurgery, Inc.
-
Annual Revenue
$76.86 M22as on Dec 31, 2022
-
Net Profit
$-39.84 M-61as on Dec 31, 2022
-
EBITDA
$-31.42 M-64as on Dec 31, 2022
-
Total Equity Funding
$80.36 M (USD)
in 13 rounds
-
Latest Funding Round
$25 M (USD), Post-IPO
Jul 20, 2020
-
Investors
Boston Scientific
& 8 more
-
Employee Count
132
as on Dec 31, 2022
-
Acquired by
Boston Scientific
(Nov 29, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Apollo Endo
Apollo Endo offers a comprehensive portfolio of products and services, including Endoscopic Sleeve Gastroplasty (ESG), Transoral Outlet Reduction (TORe), and Orbera. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reduces stomach size endoscopically to facilitate weight loss.
Adjusts previous gastric bypass for effective weight management.
Occupies stomach space to suppress appetite and aid weight loss.
Unlock access to complete
Unlock access to complete
Funding Insights of Apollo Endo
Apollo Endo has successfully raised a total of $80.36M across 13 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Post-IPO — $25.0M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Post-IPO - Apollo Endo | Valuation |
investors |
|
| Aug, 2019 | Amount | Post-IPO - Apollo Endo | Valuation |
investors |
|
| Feb, 2015 | Amount | Debt – Conventional - Apollo Endo | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Apollo Endo
Apollo Endo has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, UTMB Health and PTV Healthcare Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Apollo Endo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Apollo Endo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Apollo Endo Comparisons
Competitors of Apollo Endo
Apollo Endo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Allurion, USGI Medical, ReShape, Cyted and Vibrynt, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Satiety induction through digestable gastric balloon introduced via a swallowed capsule
|
|
| domain | founded_year | HQ Location |
Incisionless operating platform for weight loss surgery
|
|
| domain | founded_year | HQ Location |
A dual intra-gastric balloon system is provided for weight loss.
|
|
| domain | founded_year | HQ Location |
Non-endoscopic diagnostics for early gastrointestinal disease detection are developed.
|
|
| domain | founded_year | HQ Location |
Provides durable coat hooks and storage solutions for home use.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Apollo Endo
Frequently Asked Questions about Apollo Endo
When was Apollo Endo founded?
Apollo Endo was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Where is Apollo Endo located?
Apollo Endo is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Who is the current CEO of Apollo Endo?
Chas McKhann is the current CEO of Apollo Endo.
Is Apollo Endo a funded company?
Apollo Endo is a funded company, having raised a total of $80.36M across 13 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $50M, raised on Jun 01, 2006.
How many employees does Apollo Endo have?
As of Dec 31, 2022, the latest employee count at Apollo Endo is 132.
What is the annual revenue of Apollo Endo?
Annual revenue of Apollo Endo is $76.86M as on Dec 31, 2022.
What does Apollo Endo do?
Apollo Endo was founded in 2005 in Austin, United States, focusing on medical devices within the gastrointestinal sector. Therapeutic solutions for obesity and related disorders are developed, including the Orbera intragastric balloon for portion control and weight management. Additional products encompass the OverStitch Endoscopic Suturing System for advanced endoscopic procedures and the LAP-BAND adjustable gastric banding system. Operations emphasize endoscopic innovations to support clinical applications.
Who are the top competitors of Apollo Endo?
Apollo Endo's top competitors include Allurion, ReShape and GT Metabolic Solutions.
What products or services does Apollo Endo offer?
Apollo Endo offers Endoscopic Sleeve Gastroplasty (ESG), Transoral Outlet Reduction (TORe), and Orbera.
Who are Apollo Endo's investors?
Apollo Endo has 9 investors. Key investors include Boston Scientific, UTMB Health, PTV Healthcare Capital, Athyrium Capital Management, and Remeditex.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.